A low-cost, multiplexed and label-free platform for life-science research and diagnostic test development
Delta Diagnostics
Delta Diagnostics envisions a world in which new multiplexed and sensitive diagnostic tests can be developed rapidly and at low cost. By developing the technology enabling this, Delta Diagnostics contributes to reduced healthcare expenditure and better patient outcome.
Technology
Delta Diagnostics has developed a novel biosensing technology based on Photonic Integrated Circuits, or optical chips, which are read-out with our small and inexpensive instruments. Optical chips enable label-free, highly-multiplexed detection of biomolecules in small samples in a matter of minutes. The combination of these characteristics makes the technology ideally suited for life-science research and diagnostics.
Team
Bart de Boer
Chief Technology Officer
Marcel van Kasteel
Chief Executive Officer
Luc Schmitt
Chief Financial Officer
Ronald Vos
Senior Director Business Development
Peter Harmsma
Manager Product Development
Corné van den Kieboom
Assay Developer
